EDP Sciences logo
Subscriber Authentication Point
Rechercher
Menu
Accueil Tous les numéros Volume 41 / Numéro 8-9 (Août-Septembre 2025) Med Sci (Paris), 41 8-9 (2025) 657-665 References
Open Access
Issue
Med Sci (Paris)
Volume 41, Number 8-9, Août-Septembre 2025
Page(s) 657 - 665
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2025099
Published online 8 septembre 2025
  1. Kaur G, Singh NK. The role of inflammation in retinal neurodegeneration and degenerative diseases. Int J Mol Sci 2022; 2022 : 386. [Google Scholar]
  2. Kaur G, Singh NK. Inflammation and retinal degenerative diseases. Neural Regen Res 2023; 2023 : 513–8. [Google Scholar]
  3. Ahmad A, Ahsan H. Biomarkers of inflammation and oxidative stress in ophthalmic disorders. J Immunoassay Immunochem 2020; 2020 : 257–71. [Google Scholar]
  4. Tham Y-C, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 2014; 2014 : 2081–90. [Google Scholar]
  5. Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA 2014; 2014 : 1901–11. [Google Scholar]
  6. Vohra R, Tsai JC, Kolko M. The role of inflammation in the pathogenesis of glaucoma. Surv Ophthalmol 2013; 2013 : 311–20. [Google Scholar]
  7. Killer HE, Pircher A. Normal tension glaucoma: review of current understanding and mechanisms of the pathogenesis. Eye 2018; 2018 : 924–30. [Google Scholar]
  8. Vohra R, Dalgaard LM, Vibæk J, et al. Potential metabolic markers in glaucoma and their regulation in response to hypoxia. Acta Ophthalmol 2019; 2019 : 567–76. [Google Scholar]
  9. Sreekumar PG, Hinton DR, Kannan R. The emerging role of senescence in ocular disease. Oxid Med Cellr Longev 2020; 2020 : 2583601. [Google Scholar]
  10. Pinazo-Durán MD, Gallego-Pinazo R, García-Medina JJ, et al. Oxidative stress and its downstream signaling in aging eyes. Clin Interv Aging 2014; 2014 : 637–52. [Google Scholar]
  11. Liu Q, Ju W-K, Crowston JG, et al. Oxidative stress is an early event in hydrostatic pressure–induced retinal ganglion cell damage. IOVS 2007; 2007 : 4580–9. [Google Scholar]
  12. Yu J, Zhong Y, Cheng Y, et al. Effect of high hydrostatic pressure on the expression of glutamine synthetase in rat retinal Müller cells cultured in vitro. Exp Ther Med 2011; 2011 : 513–6. [Google Scholar]
  13. Tök L, Nazıroğlu M, Uğuz AC, Tök Ö. Elevated hydrostatic pressures induce apoptosis and oxidative stress through mitochondrial membrane depolarization in PC12 neuronal cells: acell culture model of glaucoma. J Recept Signal Transduct 2014; 2014 : 410–6. [Google Scholar]
  14. Hernandez MR, Pena JDO, Selvidge JA, et al. Hydrostatic pressure stimulates synthesis of elastin in cultured optic nerve head astrocytes. Glia 2000; 2000 : 122–36. [Google Scholar]
  15. Saccà SC, Tirendi S, Scarfì S, et al. An advanced in vitro model to assess glaucoma onset. ALTEX 2020; 2020 : 265–74. [Google Scholar]
  16. Wang Y, Zhong Y, Zhang L, et al. Global incidence, progression, and risk factors of age-related macular degeneration and projection of disease statistics in 30 years: a modeling study. Gerontology 2021; 2021 : 721–35. [Google Scholar]
  17. Pierre M, Lamaa D, Fabre M, et al. Traitement topique de la dégénérescence maculaire liée à l’âge. Med Sci (Paris) 2023; 2023 : 958–66. [Google Scholar]
  18. Fleckenstein M, Schmitz-Valckenberg S, Chakravarthy U. Age-Related Macular Degeneration: A Review. JAMA 2024; 2024 : 147–57. [Google Scholar]
  19. Behar-Cohen F, Sennlaub F, Berdugo M. Espoirs thérapeutiques dans la dégénérescence maculaire liée à l’âge. Med Sci (Paris) 2007; 2007 : 127–9. [Google Scholar]
  20. Leveziel N, Soubrane G, Souied EH. Anti-VEGF : applications pratiques en ophtalmologie. Med Sci (Paris) 2009; 2009 : 1105–7. [Google Scholar]
  21. Roubeix C, Sahel J-A, Guillonneau X, et al. Sur les origines inflammatoires de la DMLA. Med Sci (Paris) 2020; 2020 : 886–92. [Google Scholar]
  22. Chan N, He S, Spee CK, et al. Attenuation of choroidal neovascularization by histone deacetylase inhibitor. PLOS One 2015; 2015 : e0120587. [Google Scholar]
  23. Losso JN, Truax RE, Richard G. Trans-resveratrol inhibits hyperglycemia-induced inflammation and connexin downregulation in retinal pigment epithelial cells. J Agric Food Chemi 2010; 2010 : 8246–52. [Google Scholar]
  24. Izumi-Nagai K, Nagai N, Ohgami K, et al. Inhibition of choroidal neovascularization with an anti-inflammatory carotenoid astaxanthin. IOVS 2008; 2008 : 1679–85. [Google Scholar]
  25. Al Gwairi O, Osman N, Getachew R, et al. Multiple growth factors, but not VEGF, stimulate glycosaminoglycan hyperelongation in retinal choroidal endothelial cells. Intl J Biol Sci 2016; 12. [Google Scholar]
  26. Liu X, Zhu M, Yang X, et al. Inhibition of RACK1 ameliorates choroidal neovascularization formation in vitro and in vivo. Exp Mol Pathol 2016; 2016 : 451–9. [Google Scholar]
  27. Fontaine V, Fournié M, Monteiro E, et al. A2E-induced inflammation and angiogenesis in RPE cells in vitro are modulated by PPAR-α, -β/δ, -γ, and RXR antagonists and by norbixin. Aging (Albany NY) 2021; 2021 : 22040–58. [Google Scholar]
  28. Djigo AD, Bérubé J, Landreville S, Proulx S. Characterization of a tissue-engineered choroid. Acta Biomater 2019; 2019 : 305–16. [Google Scholar]
  29. Nebel C, Aslanidis A, Rashid K, Langmann T. Activated microglia trigger inflammasome activation and lysosomal destabilization in human RPE cells. BBRC 2017; 2017 : 681–6. [Google Scholar]
  30. Ma W, Zhao L, Fontainhas AM, et al. Microglia in the mouse retina alter the structure and function of retinal pigmented epithelial cells: a potential cellular interaction relevant to AMD. PLOS One 2009; 2009 : e7945. [Google Scholar]
  31. Yau JWY, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes care 2012; 2012 : 556–64. [Google Scholar]
  32. Frey T, Antonetti DA. Alterations to the blood-retinal barrier in diabetes: cytokines and reactive oxygen species. Antioxid Redox Signal 2011; 2011 : 1271–84. [Google Scholar]
  33. Zhang X, Zeng H, Bao S, et al. Diabetic macular edema: new concepts in patho-physiology and treatment. Cell Biosci 2014; 2014 : 1–14. [Google Scholar]
  34. Rübsam A, Parikh S, Fort PE. Role of inflammation in diabetic retinopathy. Int J Mol Sci 2018; 2018 : 942. [Google Scholar]
  35. Stitt AW, Curtis TM, Chen M, et al. The progress in understanding and treatment of diabetic retinopathy. Prog Retin Eye Res 2016; 2016 : 156–86. [Google Scholar]
  36. Kim M-K, Kim S-G, Lee SK. 4-Hexylresorcinol induced angiogenesis potential in human endothelial cells. Maxillofac Plast Reconstr Surg 2020; 2020 : 23. [Google Scholar]
  37. Durham JT, Dulmovits BM, Cronk SM, et al. Pericyte chemomechanics and the angiogenic switch: insights into the pathogenesis of proliferative diabetic retinopathy? IOVS 2015; 2015 : 3441–59. [Google Scholar]
  38. Gong Y, Fu Z, Edin ML, et al. Cytochrome P450 oxidase 2C inhibition adds to ω-3 long-chain polyunsaturated fatty acids protection against retinal and choroidal neovascularization. Arterioscler Thromb Vasc Biol 2016; 2016 : 1919–27. [Google Scholar]
  39. Yu Z, Zhang T, Gong C, et al. Erianin inhibits high glucose-induced retinal angiogenesis via blocking ERK1/2-regulated HIF-1α-VEGF/VEGFR2 signaling pathway. Sci Rep 2016; 2016 : 34306. [Google Scholar]
  40. Johnen S, Djalali-Talab Y, Kazanskaya O, et al. Antiangiogenic and neurogenic activities of sleeping beauty-mediated PEDF-transfected RPE cells in vitro and in vivo. BioMed Res Int 2015; 2015 : 863845. [Google Scholar]
  41. Spuul P, Daubon T, Pitter B, et al. VEGF-A/Notch-induced podosomes proteolyse basement membrane collagen-IV during retinal sprouting angiogenesis. Cell Rep 2016; 2016 : 484–500. [Google Scholar]
  42. Siemerink MJ, Hughes MR, Dallinga MG, et al. CD34 promotes pathological epi-retinal neovascularization in a mouse model of oxygen-induced retinopathy. PLOS One 2016; 2016 : e0157902. [Google Scholar]
  43. Sadikan MZ, Abdul Nasir NA, Lambuk L, et al. Diabetic retinopathy: a comprehensive update on in vivo, in vitro and ex vivo experimental models. BMC Ophthalmol 2023; 2023 : 421. [Google Scholar]
  44. Bergers G, Song S. The role of pericytes in blood-vessel formation and maintenance. Neuro-Oncol 2005; 2005 : 452–64. [Google Scholar]
  45. Rungger–Brändle E, Dosso AA, Leuenberger PM. Glial reactivity, an early feature of diabetic retinopathy. IOVS 2000; 2000 : 1971–80. [Google Scholar]
  46. Eyre JJ, Williams RL, Levis HJ. A human retinal microvascular endothelial-pericyte co-culture model to study diabetic retinopathy in vitro. Exp Eye Res 2020; 2020 : 108293. [Google Scholar]
  47. Lupo G, Agafonova A, Cosentino A, et al. Protective effects of human pericyte-like adipose-derived mesenchymal stem cells on human retinal endothelial cells in an in vitro model of diabetic retinopathy: evidence for autologous cell therapy. Int J Mol Sci 2023; 2023 : 913. [Google Scholar]
  48. Stryker ZI, Rajabi M, Davis PJ, Mousa SA. Evaluation of angiogenesis assays. Biomedicines 2019; 2019 : 37. [Google Scholar]
  49. Papadopoulos N, Martin J, Ruan Q, et al. Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab. Angiogenesis 2012; 2012 : 171–85. [Google Scholar]
  50. Hamilton RD, Leach L. Isolation and properties of an in vitro human outer blood-retinal barrier model. Methods Mol Biol 2011 : 401–16. [Google Scholar]
  51. Galloway CA, Dalvi S, Shadforth AMA, et al. Characterization of human iPSC-RPE on a prosthetic Bruch’s membrane manufactured from silk fibroin. IOVS 2018; 2018 : 2792–800. [Google Scholar]
  52. Raîche-Marcoux G, Guérin S, Boisselier É. Modèles cellulaires des maladies inflammatoires du segment antérieur de l’œil. Med Sci (Paris) 2025; 2025 : 327–35. [Google Scholar]
  53. Jiang S, Kametani M, Chen DF. Adaptive Immunity: New Aspects of Pathogenesis Underlying Neurodegeneration in Glaucoma and Optic Neuropathy. Front Immunol 2020; 11 : 65. [Google Scholar]
  54. Fleckenstein M, Keenan TDL, Guymer RH, et al. Age-related macular degeneration. Nat Rev Dis Primers 2021; 2021 : 31. [Google Scholar]
  55. Chauhan MZ, Rather PA, Samarah SM, et al. Current and novel therapeutic approaches for treatment of diabetic macular edema. Cells 2022; 2022 : 1950. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.